Management of ACCF/AHA Stage A and B patients.

Faiz Subzposh, Ashwani Gupta, Shelley R Hankins, Howard J Eisen

Journal: Cardiology clinics 2014;32(1):63-71, viii

PMID: 24286579

Full Text on Elsevier Science View on PubMed

Abstract

Heart failure remains a major health problem in the United States, affecting 5.8 million Americans. Its prevalence continues to rise due to the improved survival of patients. Despite advances in treatment, morbidity and mortality remain very high, with a median survival of about 5 years after the first clinical symptoms. This article describes the causes, classification, and management goals of heart failure in Stages A and B.

Address: Division of Cardiology, Drexel University College of Medicine, 245 North 15th Street, Mailstop #1012, Philadelphia, PA 19102, USA.

DOI: 10.1016/j.ccl.2013.09.003

Link outs

Free resources

Medical:

https://medlineplus.gov/heartfailure.html

Other Literature Sources:

https://scite.ai/reports/24286579

Subscription / membership required

Full Text Sources:

MeSH Terms: Adrenergic beta-Antagonists, Alcohol Drinking, Angiotensin-Converting Enzyme Inhibitors, Cardiac Pacing, Artificial, Cardiotonic Agents, Cardiotoxins, Coronary Artery Disease, Defibrillators, Implantable, Diabetic Cardiomyopathies, Digoxin, Dyslipidemias, Early Diagnosis, Endocrine System Diseases, HIV Infections, Heart Failure, Humans, Hypertension, Metabolic Syndrome, Mineralocorticoid Receptor Antagonists, Renal Insufficiency, Chronic, Risk Factors, Sedentary Behavior, Sleep Apnea Syndromes, Smoking, Tachycardia